UBS AM’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.3M | Buy |
856,597
+677,234
| +378% | +$17.6M | ﹤0.01% | 1010 |
|
|
2025
Q1 | $4.39M | Buy |
179,363
+53,461
| +42% | +$1.31M | ﹤0.01% | 1639 |
|
|
2024
Q4 | $3.61M | Buy |
125,902
+104,780
| +496% | +$3.01M | ﹤0.01% | 1764 |
|
|
2024
Q3 | $797K | Sell |
21,122
-2,503
| -11% | -$94.4K | ﹤0.01% | 2488 |
|
|
2024
Q2 | $746K | Buy |
+23,625
| New | +$746K | ﹤0.01% | 2504 |
|